Health Condition 1: null- keratoconus and corneal ectatic conditions
Conditions
Interventions
Intervention1: Continuous mode accelerated KXL: Patients with Keratoconus will be treated with Continuous mode KXL-with a UV-A power setting at 30â??mW/cm2 for 3 minutes of continuous UV-A light expos
Sponsors
Nethradhama Superspeciality eye Hospital
Eligibility
Inclusion criteria
Inclusion criteria: • Worsening of uncorrected distance visual acuity (UDVA) or best corrected distance visual acuity (BDVA) of > 0.50 Snellen lines • Increase of manifest spherical or cylindrical refractive error of > 0.50 Diopter • Increase in steepest keratometry value (on Sim K or Manual) by >=1D • Increase in mean K reading >= 1â??D • Reduction of the thinnest point at corneal optical coherence tomography (OCT) pachymetry >=10â??μm
Exclusion criteria
Exclusion criteria: • Thin corneas ( Corneal pachymetry at thinnest point • Prior herpetic infection because it may result in viral reactivation • Concurrent infection • Severe corneal scarring or opacification • History of poor epithelial wound healing • Severe ocular surface disease ( moderate to severe dry eyes Schirmer test I • Autoimmune disorders • Pregnant and nursing mother • Previous intraocular and corneal surgery • Glaucoma or IOP higher than 24mmHg
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the pulsed mode with the continuous mode of accelerated corneal collagen cross linking (KXL) in terms of efficacy and safety for keratoconus.Timepoint: Follow-up on day 1, ady 5, day 30 , 3 months and 6 months post-operatively. | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the quality to vision and post-operative complications if any.Timepoint: Follow-up on day 1, ady 5, day 30 , 3 months and 6 months post-operatively. | — |
Countries
India
Contacts
Public ContactKirti Relekar
NETHRADHAMA SUPERSPECIALITY EYE HOSPITAL
Outcome results
None listed